Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Ранг среди акций #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Цена акции
$0.07600875
Последняя синхронизация: 2024-11-20
Рыночная капитализация
$2.06M
Изменение (1 день)
-0.51%
Изменение (1 год)
0.00%
Страна
FR
Торговля Quantum Genomics S.A. (ALQGC)

Категория

Коэффициент P/B для Quantum Genomics S.A. (ALQGC)
Коэффициент P/B на August 2026 TTM: -2.05
Согласно последним финансовым отчетам и цене акций Quantum Genomics S.A., текущий коэффициент P/B (TTM) составляет -2.05. В конце 2023 он составлял 8.46.
История P/B для Quantum Genomics S.A. с 2009 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) -2.05 -0.18%
2024 -2.05 -124.18%
2023 8.46 649.27%
2022 1.13 -90.55%
2021 11.95 194.68%
2020 4.06 -37.21%
2019 6.46 -8.65%
2018 7.07 87.24%
2017 3.78 -35.35%
2016 5.84 -20.06%
2015 7.31 -103.58%
2014 -204.14 1,261.27%
2013 -15.00 -41.14%
2012 -25.48 74.82%
2011 -14.57 70.19%
2010 -8.56 -101.36%
2009 630.17 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -409.91%
US
6.2413 -404.99%
NL
- -
CH
- -
KR
3.4612 -269.14%
BE